RU2109510C1 - Способ ингибирования, таблетка и капсула - Google Patents

Способ ингибирования, таблетка и капсула Download PDF

Info

Publication number
RU2109510C1
RU2109510C1 RU96108120A RU96108120A RU2109510C1 RU 2109510 C1 RU2109510 C1 RU 2109510C1 RU 96108120 A RU96108120 A RU 96108120A RU 96108120 A RU96108120 A RU 96108120A RU 2109510 C1 RU2109510 C1 RU 2109510C1
Authority
RU
Russia
Prior art keywords
dye
red
yellow
thienyl
pigment
Prior art date
Application number
RU96108120A
Other languages
English (en)
Russian (ru)
Other versions
RU96108120A (ru
Inventor
Ньюлин Виллард (младший)
М.Лафлин Шарон
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Application granted granted Critical
Publication of RU2109510C1 publication Critical patent/RU2109510C1/ru
Publication of RU96108120A publication Critical patent/RU96108120A/ru

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883Capsule finishing, e.g. dyeing, aromatising, polishing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU96108120A 1995-04-24 1995-04-24 Способ ингибирования, таблетка и капсула RU2109510C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IBPCT/IB95/00287 1995-04-24
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (2)

Publication Number Publication Date
RU2109510C1 true RU2109510C1 (ru) 1998-04-27
RU96108120A RU96108120A (ru) 1998-07-10

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96108120A RU2109510C1 (ru) 1995-04-24 1995-04-24 Способ ингибирования, таблетка и капсула

Country Status (30)

Country Link
EP (1) EP0827399A1 (fi)
JP (1) JPH10506635A (fi)
KR (1) KR100189585B1 (fi)
CN (1) CN1053667C (fi)
AP (1) AP607A (fi)
AR (1) AR002728A1 (fi)
AU (1) AU692378B2 (fi)
BG (1) BG100531A (fi)
BR (1) BR9602024A (fi)
CO (1) CO4700418A1 (fi)
FI (1) FI973988A (fi)
HR (1) HRP960194A2 (fi)
HU (1) HU216544B (fi)
IL (1) IL117969A0 (fi)
IS (1) IS4339A (fi)
MA (1) MA23848A1 (fi)
NO (1) NO961622L (fi)
NZ (1) NZ286432A (fi)
OA (1) OA10286A (fi)
PE (1) PE34397A1 (fi)
RO (1) RO113305B1 (fi)
RU (1) RU2109510C1 (fi)
SG (1) SG64924A1 (fi)
SI (1) SI9600133A (fi)
SK (1) SK51296A3 (fi)
TR (1) TR199600300A2 (fi)
UA (1) UA42739C2 (fi)
WO (1) WO1996033701A1 (fi)
YU (1) YU25096A (fi)
ZA (1) ZA963210B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526730B (zh) 2017-12-29 2024-02-23 卡夫食品集团品牌有限责任公司 使用天然稳定剂改善的水包油乳液的氧化稳定性

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. RU 2017729 С (Пфайзер Инк.), 15.08.94, A 61 K 31/40. 2. DE 3526546 А1 (R.P.Scherer GmbH), 29.01.87, A 61 K 9/48. 3. US 3784684 А (Friedrich Bossert и др.), 08.01.74, колонка 3, A 61 J 3/07. 4. JP 60-105611 А (Nippon Chemipher K.K.), 11.06.85, A 61 K 9/48. 5. *

Also Published As

Publication number Publication date
FI973988A0 (fi) 1997-10-17
AP9600787A0 (en) 1996-04-30
YU25096A (sh) 1998-08-14
AU5085196A (en) 1996-11-07
BG100531A (en) 1997-06-30
AP607A (en) 1997-08-27
CN1139110A (zh) 1997-01-01
EP0827399A1 (en) 1998-03-11
UA42739C2 (uk) 2001-11-15
IS4339A (is) 1996-10-25
TR199600300A2 (tr) 1996-11-21
FI973988A (fi) 1997-10-17
IL117969A0 (en) 1996-08-04
PE34397A1 (es) 1997-09-29
SI9600133A (en) 1996-10-31
CO4700418A1 (es) 1998-12-29
HU9601057D0 (en) 1996-06-28
OA10286A (en) 1997-09-19
AR002728A1 (es) 1998-04-29
CN1053667C (zh) 2000-06-21
HUP9601057A3 (en) 1997-05-28
KR100189585B1 (ko) 1999-06-01
KR960037656A (ko) 1996-11-19
HU216544B (hu) 1999-07-28
NZ286432A (en) 1998-05-27
ZA963210B (en) 1997-10-23
SK51296A3 (en) 1997-04-09
RO113305B1 (ro) 1998-06-30
NO961622D0 (no) 1996-04-23
HRP960194A2 (en) 1998-02-28
JPH10506635A (ja) 1998-06-30
NO961622L (no) 1996-10-25
MA23848A1 (fr) 1996-12-31
HUP9601057A2 (en) 1997-04-28
WO1996033701A1 (en) 1996-10-31
BR9602024A (pt) 1998-10-06
AU692378B2 (en) 1998-06-04
SG64924A1 (en) 1999-05-25

Similar Documents

Publication Publication Date Title
JP3254219B2 (ja) 安定な経口用のci−981製剤およびその製法
RU2426530C2 (ru) Твердый препарат
FI92904B (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
FR2684876A1 (fr) Compositions pharmaceutiques stabilisees comprenant un compose inhibiteur de la hmg-coa reductase et procede pour leur preparation.
CA2501587C (en) Solid preparation having phase containing insulin sensitizer and another active ingredient uniformly mixed
JPWO2005099760A1 (ja) 固形製剤
EA199700098A1 (ru) Производные индола, пригодные для лечения остеопороза
NL193440C (nl) Farmaceutisch preparaat met analgetische werking.
MXPA04011801A (es) Composicion farmaceutica que contiene oxcarbazepina con liberacion controlada de la substancia activa.
KR20100012105A (ko) 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌 소르비탄 지방산 에스테르를 함유하는 고체 제제
FR2931677A1 (fr) Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs
RU2109510C1 (ru) Способ ингибирования, таблетка и капсула
CA2003478A1 (en) Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
RU2292891C2 (ru) Фармацевтическая композиция с антигиперлипидемической активностью
US5789407A (en) Method of treating depression with certain triazine derivatives
AU780341B2 (en) Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone
CA2216931A1 (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
AU620658B2 (en) Memory-enhancing compositions containing dioxopiperidine derivatives
US4333945A (en) Thiazoline and imidazoline derivatives useful as minor tranquilizers
GB2206491A (en) Anti-anxiogenic compositions containing dioxopiperidine derivatives
US5177086A (en) Memory-enhancing compositions containing dioxopiperidine derivatives
KR19990022917A (ko) 양성 전립선 비대증 치료용 멜라토닌 효능제
RU96108120A (ru) Способ ингибирования, таблетка и капсула
TH11684B (th) สารผสมทางเภสัชกรรมที่เสถียรซึ่งประกอบด้วยสารยับยั้ง HMG-CoA รีดักเตส
MXPA00004573A (en) Novel oral dosage form for carvedilol